JOIN A STUDY

Access quality healthcare while helping advance medical breakthroughs

Enrolling! Contact a study coordinator with questions

A young child receiving a vaccine shot in their arm from a healthcare professional wearing blue gloves, with the text 'Vaccine Study' at the bottom.

Merck Sharpe & Dohme's Pneumoccocal Vaccine

Phase 1, Randomized, Double-Blind, Active Comparator Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Novel Pneumococcal Vaccine in Children

Stage 1: Healthy toddlers 12 through 15 months of age who have previously completed a 3-dose routine infant series with PCV20

Stage 2: Healthy infants approximately 2 months of age (42 days to 90 days)

For more info: https://clinicaltrials.gov/study/NCT07300267

Primary Coordinator: KaTia Whindleton (KaTia@proc211.com)

A young girl appears to be experiencing a headache, with her eyes closed and hands pressing against her temples, indicating migraine pain, on a promotional graphic for migraine study.

Pfizer Long-term Migraine Treatment

Phase 3, multicenter, open-label study to assess the long-term safety and tolerability of Rimegepant for the acute treatment of migraine (with or without aura) in children and adolescents ≥ 6 to <18 years of age

For more info: https://clinicaltrials.gov/study/NCT04743141?id=C4951003&rank=1

Primary Coordinator: Cheryll Caalim (Cheryll@proc211.com)

A young boy holding his head in pain, with a distressed expression, on a background with paper cutouts in green and blue. Text reads 'Migraine Study'.

Pfizer Rimegepant Migraine Treatment

Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of Rimegepant for the treatment of migraine (with or without aura) in children and adolescents ≥ 6 to <18 years of age.

For more info: https://clinicaltrials.gov/study/NCT04649242

Primary Coordinator: Cheryll Caalim (Cheryll@proc211.com)

A child receiving a vaccination shot in their upper arm from a healthcare worker wearing blue gloves, with the text 'Vaccine Study' below.

Pfizer 4th Gen Pneumoccocal Vaccine

4th Generation Pneumococcal Vaccine Children ≥ 15 Months to < 5 Years of Age.

For more info: https://clinicaltrials.gov/study/NCT07660198

Primary Coordinator: KaTia Whindleton (KaTia@proc211.com)

Child receiving a vaccine shot in the arm from a healthcare professional wearing gloves.

Pfizer 4th Gen Pneumoccocal Vaccine

4th Generation Pneumococcal Vaccine Infants 2 months of age (≥42 to ≤98 days)

Primary Coordinator: Cheryll Caalim (Cheryll@proc211.com)

A young boy with dark hair and a gray T-shirt holding his forehead with a pained expression, indicating a headache or discomfort, with the text 'Migraine Study' at the bottom.

AbbVie Ubrogepant Migraine Medication

Ubrogepant for acute treatment of migraines (Randomized, double-blind, placebo-controlled)  

Adolescents Ages 12-17 years with migraine with or without aura

Primary Coordinator: KaTia Whindleton (KaTia@proc211.com)

A young woman with closed eyes holding her head in pain, with a gray background and a blue overlay with wavy edges, and the text 'Migraine Study' at the bottom.

AbbVie Ubrogepant Migraine Medication

Ubrogepant for acute treatment of migraines (Open-label, extension study)

Adolescents Ages 12-17 years with migraine with or without aura

Primary Coordinator: KaTia Whindleton (KaTia@proc211.com)

A young girl sitting on a bed with her hand on her stomach, looking uncomfortable, with a window in the background, indicating a constipation study.

Bausch Health Plecanatide Functional Constipation Medication

Plecanatide (Trulance)

(Randomized, double-blind, placebo-controlled)

Children and adolescents 6 < 18 years with functional constipation

Primary Coordinator: Lucy Friedman (Lucy@proc211.com)

Enrolling Soon!

A young girl with long brown hair, smiling and laughing, showing her teeth. She is wearing a white tank top and has a bandage on her upper arm, indicating she received a vaccine. The background features a yellow color with a blue border, and the text 'Vaccine Study' is written at the bottom.

GlaxoSmithKlein MMRVNS Vaccine

Phase 3a, Observer-Blind, Randomized, Controlled Study... to Evaluate the Immunogenicity and Safety of an Investigational Combined Measles, Mumps, Rubella, and Varicella Vaccine

Children Ages 4-6 Years with < 2 Prior MMR Vaccines

For more info: https://clinicaltrials.gov/study/NCT07742644

Primary Coordinator: Bradley Rotondi (Bradley@proc211.com)

COVID-19 rapid test kit, an swab, and a test tube on a blue background with the text 'Device Study'

STUDYBOX device for Home Testing for Flu A, B, Covid, and RSV

Starting in October

For more info: https://clinicaltrials.gov/study/NCT07742644

Primary Coordinator: Jack Wisman (Jack@proc211.com)

Close-up of a woman's face with acne, touching her cheek, with text 'Acne Study' at the bottom.

Sanofi Teen Acne Vaccine

Starting in January 2027

Primary Coordinator: Cheryll Caalim (Cheryll@proc211.com)

Studies Currently in Follow-Up

A young child receiving a vaccine shot from a medical professional wearing blue gloves. The child is smiling and touching their mouth.

Vaxcyte 31-Valent Pneumococcal Conjugate Vaccine

Phase 2, Randomized, Double-Blind, Active-Controlled, Dose-Finding Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants Given 4 Doses at 2, 4, 6, and 12–15 Months of Age Concomitantly with Routine Pediatric Vaccines

Primary Coordinator: Cathy Hansa (Catherine@proc211.com)

For more info:

https://clinicaltrials.gov/study/NCT06720038?locStr=Charlottesville,%20VA&country=United%20States&state=Virginia&city=Charlottesville&cond=pneumococcal%2031&rank=2&tab=table

Join A Study

Sign up to be notified about the latest research studies in the Charlottesville, VA area that could give you access to new treatments and expert care.